About-cancer / lapaʻau / lāʻau / ʻili
ʻApono ʻia nā lāʻau no ka maʻi ʻaʻai
Ua helu ʻia kēia ʻaoʻao i nā lāʻau ʻaila i ʻāpono ʻia e ka Food and Drug Administration (FDA) no ka maʻi ʻaʻai ʻili, me nā lāʻau no ka carcinoma basal cell, melanoma, a me ka cancer cancer cell. Loaʻa i ka papa inoa nā inoa generic a me nā inoa inoa. Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau ke hoʻohana ʻia i ka maʻi ʻaʻai ʻili i helu ʻole ʻia ma aneʻi.
MA K PIA ʻaoʻao
- Ua ʻae ʻia nā lāʻau no Basal Cell Carcinoma
- Ua ʻae ʻia nā lāʻau no ka maʻi maʻi maʻi maʻi Cutaneous Squamous Cell
- Ua ʻae ʻia nā lāʻau no Melanoma
- Ua ʻae ʻia nā lāʻau no Merkel Cell Carcinoma
Ua ʻae ʻia nā lāʻau no Basal Cell Carcinoma
Aldara (Imiquimod)
Efudex (Fluorouracil - kumuhana)
ʻO Erivedge (Vismodegib)
5-FU (Fluorouracil - kumuhana)
Fluorouracil - kumuhana
Imiquimod
Odomzo (Sonidegib)
ʻO Sonidegib
ʻO Vismodegib
Ua ʻae ʻia nā lāʻau no ka maʻi maʻi maʻi maʻi Cutaneous Squamous Cell
Cemiplimab-rwlc
Libtayo (Cemiplimab-rwlc)
Ua ʻae ʻia nā lāʻau no Melanoma
Aldesleukin
ʻO Cobimetinib
ʻO Cotellic (Cobimetinib)
ʻO Dabrafenib
ʻO Dacarbazine
ʻO DTIC-Dome (Dacarbazine)
IL-2 (Aldesleukin)
Imlygic (Talimogene Laherparepvec)
Interleukin-2 (Aldesleukin)
Intron A (Recombinant Interferon Alfa-2b)
Ipilimumab
Keytruda (Pembrolizumab)
Mekinist (Trametinib)
ʻO Nivolumab
Opdivo (Nivolumab)
Peginterferon Alfa-2b
Pembrolizumab
Proleukin (Aldesleukin)
ʻO Recombinant Interferon Alfa-2b
Sylatron (Peginterferon Alfa-2b)
Tafinlar (Dabrafenib)
ʻO Talimogene Laherparepvec
Trametinib
ʻO Vemurafenib
Yervoy (Ipilimumab)
Zelboraf (Vemurafenib)
Ua ʻae ʻia nā lāʻau no Merkel Cell Carcinoma
ʻAvelumab
Bavencio (Avelumab)
Keytruda (Pembrolizumab)
Pembrolizumab
